2-(4-氟苯氧基)-3-硝基吡啶 | 147143-58-6

• 物质功能分类: 医药中间体 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 2-(4-氟苯氧基)-3-硝基吡啶
• 中文别名: 2-(4-氟代苯氧基)-3-硝基吡啶
• 英文名称: 2-(4-fluorophenoxy)-3-nitropyridine
• CAS: 147143-58-6
• 化学式: C₁₁H₇FN₂O₃
• mdl: MFCD00067801
• 分子量: 234.187
• InChiKey: CCUGBHTWDHSEOA-UHFFFAOYSA-N

物化性质

• 熔点：
  98 °C
• 溶解度：
  31.6 [ug/mL]

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  67.9
• 氢给体数：
  0
• 氢受体数：
  5

安全信息

• 危险等级：
  TOXIC
• 危险品标志：
  T
• 安全说明：
  S26,S36,S37,S39
• 危险类别码：
  R20/21/22
• 海关编码：
  2933399090

SDS

Name:	2-(4-Fluorophenoxy)-3-nitropyridine 97% Material Safety Data Sheet
Synonym:
CAS:	147143-58-6

Section 1 - Chemical Product MSDS Name:2-(4-Fluorophenoxy)-3-nitropyridine 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
147143-58-6	2-(4-Fluorophenoxy)-3-nitropyridine	97%	unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 147143-58-6: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: light brown
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 98 - 99 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C11H7FN2O3
Molecular Weight: 234

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide, fluorine, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 147143-58-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-(4-Fluorophenoxy)-3-nitropyridine - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 147143-58-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 147143-58-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 147143-58-6 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为产物：
  描述：

  2-氯-3-硝基吡啶 、 4-氟苯酚 在 sodium hydride 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 1.33h， 生成 2-(4-氟苯氧基)-3-硝基吡啶
  参考文献：
  名称：

  [EN] PYRROLO[2,3-c]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF
  [FR] DERIVES DE PYRROLO[2,3-C]PYRIDINE ET LEURS PROCEDES DE PREPARATION

  摘要：

  本发明提供了新颖的吡咯并[2,3-c]吡啶衍生物或其药用可接受的盐，以及其制备的方法和包含相同的组合物。本发明的吡咯并[2,3-c]吡啶衍生物或其药用可接受的盐具有优异的质子泵抑制效果，并具有达到可逆的质子泵抑制效果的能力。

  公开号：

  WO2006025717A1

文献信息

• [EN] PYRROLO[3,2-B]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF<br/>[FR] DERIVES DE PYRROLO[3,2-B]PYRIDINE ET LEURS PROCEDES DE PREPARATION
  申请人：YUHAN CORP

  公开号：WO2006038773A1

  公开（公告）日：2006-04-13

  The present invention provides novel pyrrolo[3,2-b]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[3,2-b]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.

  本发明提供了新颖的吡咯并[3,2-b]吡啶衍生物或其药用可接受盐，以及其制备方法和包含它们的组合物。本发明的吡咯并[3,2-b]吡啶衍生物或其药用可接受盐具有出色的质子泵抑制效果，并具有获得可逆质子泵抑制效果的能力。
• PYRROLO[3,2-B]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF
  申请人：Kim Jae-Gyu

  公开号：US20070213358A1

  公开（公告）日：2007-09-13

  The present invention provides novel pyrrolo[3,2-b]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[3,2-b]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.

  本发明提供了新型吡咯并[3,2-b]吡啶衍生物或其药学上可接受的盐，其制备方法和包含它们的组合物。本发明的吡咯并[3,2-b]吡啶衍生物或其药学上可接受的盐具有出色的质子泵抑制效果，并具有可逆的质子泵抑制效果。
• Pyrrolo[3,2-B]pyridine derivatives and processes for the preparation thereof
  申请人：Yuhan Corporation

  公开号：US07642269B2

  公开（公告）日：2010-01-05

  The present invention provides novel pyrrolo[3,2-b]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[3,2-b]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.

  本发明提供了新型吡咯并[3,2-b]吡啶衍生物或其药学上可接受的盐，制备方法和包含它们的组合物。本发明的吡咯并[3,2-b]吡啶衍生物或其药学上可接受的盐具有出色的质子泵抑制效果，并具有获得可逆的质子泵抑制效果的能力。
• NICOTINAMIDE DERIVATIVES
  申请人：Pfizer Products Inc.

  公开号：EP0971894A1

  公开（公告）日：2000-01-19
• US6380218B1
  申请人：——

  公开号：US6380218B1

  公开（公告）日：2002-04-30